Sanofi's Dupixent gets U.S. approval to treat eczema in young children
Reuters via Yahoo News· 1 year agoDupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...
Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids
Zacks via Yahoo Finance· 6 months agoSanofi (SNY) and Regeneron's Dupixent becomes the first and only targeted medicine approved to treat...
Danielle Jonas says her eczema affected her self-esteem and deterred her from going on tour often...
INSIDER via Yahoo News· 2 months agoDanielle Jonas opened up about her eczema journey in a recent interview with Insider.Courtesy of...
Eczema and the COVID-19 Vaccine: Is it Safe?
Verywell Health via Yahoo News· 11 months agoCOVID-19 vaccines are safe for people who have eczema, an itchy rash that is the most common type of atopic dermatitis. The COVID-19 vaccines available...
Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now
Investor's Business Daily· 1 year agoAbbVie could soon pressure Regeneron Pharmaceuticals in eczema treatment, an analyst said Friday as...
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Dupixent...
ETFs in Focus on Sanofi and Regeneron's COPD Drug Data
Zacks via Yahoo Finance· 6 months agoShares of drugmakers Sanofi SNY and Regeneron REGN both surged more than 6% on Mar 23 after they...
Sanofi forecasts moderate profit growth on Dupixent demand
Reuters via Yahoo News· 8 months ago(Reuters) -Sanofi forecast moderate earnings growth that undershot expectations, saying demand for...
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Zacks via Yahoo Finance· 6 months agoThis week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 6 months agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
Yahoo Web Search
- 110 results
Trending Now
